Sign in

CIK 0001582554

  • Non-accelerated filer
  • Smaller reporting company

Matinas BioPharma Holdings, Inc.

Sign in to watch
Ticker
MTNB
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463011414
Phone
+1 908-484-8805
Business address
1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
  1. 4 Grant or award Director acquired 18,524 shares (grant or award)
  2. 4 Grant or award Director acquired 28,005 shares (grant or award)
  3. 4 Open-market buy Director bought 15,000 shares at $0.80 ($12,000)
  4. 4 Open-market buy President and CEO bought 12,487 shares at $0.80 ($9,980)
  5. 4 Open-market buy Director bought 20,000 shares at $0.80 ($15,998)
  6. 4 Open-market buy Director bought 15,000 shares at $0.82 ($12,300)
  7. 4 Open-market buy Director bought 20,000 shares at $0.89 ($17,800)
  8. 4 Open-market buy Director bought 80,000 shares at $0.94 ($75,200)
  9. 4 Open-market buy Director bought 150,000 shares at $0.95 ($142,500)
  10. 4 Open-market buy Director bought 100,000 shares at $0.95 ($95,250)
  11. 4 Open-market buy Director bought 25,000 shares at $0.96 ($24,115)
  12. 4 Grant or award Director acquired 14,565 shares (grant or award)
  13. 4 Grant or award Director acquired 22,019 shares (grant or award)
  14. 4 Grant or award Director acquired 17,202 shares (grant or award)
  15. 4/A Grant or award Director acquired 12,201 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 12 · 232 filings